On Sep 29, 2021 BioAtla closed a Post-IPO Equity round and raised $75,000,000 from Cormorant Asset Management, Deerfield Management, Great Point Partners, HBM Healthcare Investments […]
Series B – Expansion Therapeutics
On Sep 29, 2021 Expansion Therapeutics closed a Series B round and raised $80,000,000 from 5AM Ventures, Cormorant Asset Management, Kleiner Perkins, Logos Capital, Novartis […]
Post-IPO Equity – BioAtla
On Sep 29, 2021 BioAtla closed a Post-IPO Equity round and raised $75,000,000 from Cormorant Asset Management, Deerfield Management, Great Point Partners, HBM Healthcare Investments […]
Series B – Expansion Therapeutics
On Sep 29, 2021 Expansion Therapeutics closed a Series B round and raised $80,000,000 from 5AM Ventures, Cormorant Asset Management, Kleiner Perkins, Logos Capital, Novartis […]
Series A – Kytopen
On Sep 28, 2021 Kytopen closed a Series A round and raised $30,000,000 from Alexandria Venture Investments, Horizon Ventures, John Ballantyne, MassVentures, Michael Chambers, Northpond […]
Series A – Vytelle
On Sep 28, 2021 Vytelle closed a Series A round and raised $13,200,000 from Fulcrum Global Capital, Innovation In Motion, KCRise Fund, Open Prairie, Serra […]
Series B – Lifebit
On Sep 28, 2021 Lifebit closed a Series B round and raised $60,000,000 from Beacon Capital, Eurazeo, Pentech Ventures, Tiger Global Management, featuring lead investors […]
Series C – NovaSignal
On Sep 28, 2021 NovaSignal closed a Series C round and raised $37,000,000 from Alpha Edison, Reimagined Ventures, featuring lead investors Alpha Edison, Reimagined Ventures. […]
Series A – Kytopen
On Sep 28, 2021 Kytopen closed a Series A round and raised $30,000,000 from Alexandria Venture Investments, Horizon Ventures, John Ballantyne, MassVentures, Michael Chambers, Northpond […]
Series C – NovaSignal
On Sep 28, 2021 NovaSignal closed a Series C round and raised $37,000,000 from Alpha Edison, Reimagined Ventures, featuring lead investors Alpha Edison, Reimagined Ventures. […]
